TrademarkDir
TRIPTIMMUNE
LIVE

Serial Number

79225650

Owner

Debiopharm International SA

Attorney

Duane M. Byers

Filing Date

Oct 25, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TRIPTIMMUNE Trademark

Serial Number: 79225650 • Registration: 5598121

TRIPTIMMUNE is a trademark filed by Debiopharm International SA on October 25, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Debiopharm International SA (17 trademarks)

Forum "après-demain"
Lausanne CH1002 , CH

Entity Type: 99

Trademark Details

Filing Date

October 25, 2017

Registration Date

November 6, 2018

Published for Opposition

August 21, 2018

Cancellation Date

May 23, 2025

Goods & Services

Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of prostate cancer, melanoma, lung cancer, kidney cancer, bladder cancer, ovarian cancer, head and neck cancer, gastric cancer, colorectal cancer, breast cancer, mesothelioma, Hodgkin's lymphoma

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 23, 2026 INTR
CANCELLED SECTION 71
May 23, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 6, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 9, 2019 FICS
FINAL DISPOSITION PROCESSED
Feb 9, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 6, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 6, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 21, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 21, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 17, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 1, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 1, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 1, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 4, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 4, 2018 TROA
REFUSAL PROCESSED BY IB
Mar 2, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 14, 2018 RFCS
REFUSAL PROCESSED BY MPU
Feb 14, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 9, 2018 RFCR
APPLICATION FILING RECEIPT MAILED
Feb 9, 2018 MAFR
NON-FINAL ACTION WRITTEN
Feb 8, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 1, 2018 REPR

Related Trademarks

More from this Owner

TRIPTODUR CARE

TRIPTODUR CARE

TRIPTODUR CARE

TRIPTODUR CARE

LIBELULA

LIBELULA

LIBELULA

LIBELULA

LIBELULA

LIBELULA

FIBROTRAP

FIBROTRAP